Los Angeles Jury Holds Johnson & Johnson Solely at Fault for $32 Million — What It Means for Your Family
If you are reading this, someone you love may have been diagnosed with mesothelioma. Or you may have already lost them. Either way, you are sitting with a question that feels impossible: how did a product you trusted — a product you used on your children — carry something that kills? You are not crazy. You are not looking for someone to blame. A jury in Los Angeles just answered that exact question with $32 million and a finding that Johnson & Johnson was solely at fault. We are going to tell you what that verdict means, what the law allows in California, what the company will try next, and what evidence is quietly disappearing while you decide what to do. This is legal information, not legal advice — but it is written by trial lawyers who know this fight, and the consultation is free. Call us at 1-888-ATTY-911, any hour.
A California woman died in 2024 from pleural mesothelioma — the cancer that grows in the lining of the lungs and is caused by asbestos. She had used Johnson & Johnson’s talc-based baby powder on herself and her three children, starting in the 1970s. Her three children carried the case forward after her death. In June 2026, a Los Angeles jury rejected every alternative explanation Johnson & Johnson raised — including the argument that her first 21 years in Mexico City had caused the asbestos exposure — and found the company solely responsible. The verdict was $32 million. That verdict is one of more than 60,000 cancer-related lawsuits pending against Johnson & Johnson over its asbestos-contaminated talc products, a product line the company discontinued in 2020 after evidence emerged that it had known about the contamination danger for years.
We handle toxic tort cases and wrongful death claims — and the work begins the moment you call. We do not get paid unless we win your case.
How Talc Baby Powder Carries Asbestos Into the Lungs
Talc and asbestos are both naturally occurring minerals. They form under similar geological conditions and are often found near each other in the earth. When talc is mined, asbestos fibers can contaminate it — not because someone added them, but because the two minerals grew together in the same ground. Without careful mining, testing, and purification, the asbestos travels with the talc all the way from the mine to the powder on your bathroom shelf.
That is the first half of the mechanism. The second half is what happens when you open the container. Baby powder is designed to be shaken, puffed, and applied to skin — which means it is designed to become airborne. When asbestos-contaminated talc is shaken into the air, the asbestos fibers are released along with the talc particles. They are invisible. They are light enough to hang in the air for minutes after you have left the room. And they are sharp — microscopic needles that the human body cannot break down or expel.
When those fibers are inhaled, they travel deep into the lungs and lodge in the pleura — the thin membrane that lines the outside of the lungs and the inside of the chest wall. The body’s immune system tries to remove them and fails. The fibers remain, causing chronic inflammation, cellular damage, and genetic mutations that accumulate over decades. That accumulation is what becomes mesothelioma — a cancer of the pleura that is, for practical purposes, signature to asbestos exposure. Doctors do not see mesothelioma from smoking. They do not see it from background environmental exposure. They see it because asbestos fibers were inhaled, and the body spent thirty or forty years trying to wall them off until the wall turned malignant.
This is why the latency period is so long — typically 20 to 50 years, most often 30 to 40 years between first exposure and diagnosis. A woman who started using baby powder in the 1970s and was diagnosed in the 2020s fits that timeline exactly. The fibers that killed her were breathed in decades before the cancer appeared. That gap — between exposure and disease — is the central cruelty of asbestos cases, and it is also the central evidentiary challenge.
The International Agency for Research on Cancer classifies asbestos as a Group 1 carcinogen — the highest category, reserved for substances proven to cause cancer in humans. This is not a contested scientific question. The only questions in a courtroom are which product carried the fibers, whether the manufacturer knew, and whether the exposure was sufficient to cause the disease.
California’s Strict Products Liability Law — What It Means and Why It Matters
California is one of the strongest jurisdictions in the country for a person injured by a defective product. The reason traces back to a landmark California Supreme Court decision — the Greenman doctrine — that established a principle no other state had yet embraced at the time: a manufacturer is strictly liable for injuries caused by a defective product, and the injured person does not need to prove the manufacturer was negligent.
Under California’s strict products liability doctrine, a manufacturer is liable when a product it places on the market, knowing it will be used without inspection for defects, proves to have a defect that causes injury. The plaintiff need not prove negligence — only that the product was defective, the defect existed when it left the manufacturer’s control, and the defect caused the injury.
That doctrine is the foundation of every talc-mesothelioma case filed in California. The talc-based baby powder was defective because it was contaminated with asbestos — a known human carcinogen. The contamination existed when the product left Johnson & Johnson’s control. The asbestos fibers in the product caused the mesothelioma. Under strict liability, the company is responsible regardless of whether it exercised care in manufacturing. The question is not “was the company careless?” The question is “was the product dangerous, and did it cause the harm?”
California recognizes three theories of product defect: manufacturing defect (this specific unit was different from others), design defect (the entire product line is inherently dangerous), and failure to warn (the company did not warn of a known risk). In talc-asbestos cases, the design defect and failure-to-warn theories are the primary engines. The product was inherently defective because it contained asbestos, and the company failed to warn consumers that it did — or could.
The failure-to-warn theory is where the evidence of corporate knowledge becomes decisive. If Johnson & Johnson knew its talc products contained or could contain asbestos fibers, and it did not warn consumers, that is not just a design defect — it is the predicate for punitive damages. California allows punitive damages when a plaintiff proves by clear and convincing evidence that the defendant acted with malice, oppression, or fraud. A company that knows its product contains a carcinogen, conceals that knowledge, and continues to market the product to families for decades meets that standard — or at least, a jury is entitled to find that it does. That is what the Los Angeles jury in this case appears to have concluded.
California also follows a pure comparative negligence system, meaning the injured person’s own share of fault reduces — but never eliminates — their recovery. In this case, the jury found Johnson & Johnson solely at fault, which means there was no reduction at all. That sole-fault finding is powerful because it eliminates the fault apportionment the defense usually fights hardest to establish.
The Regulatory Vacuum That Let This Happen
One of the most difficult truths in these cases is that no federal agency required Johnson & Johnson to test its talc for asbestos before selling it. The FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act, but historically the agency has not required premarket approval or asbestos testing for talc-based cosmetic products. A company could mine talc, ship it, package it, and put it on store shelves without ever checking whether it contained asbestos — and the federal government would not have stopped it.
The EPA regulates asbestos under the Toxic Substances Control Act and has conducted risk evaluations, but its rulemaking on asbestos protections has been delayed repeatedly — the article references delays pushing asbestos protection rules into 2027. OSHA sets permissible exposure limits for asbestos in occupational settings — 0.1 fibers per cubic centimeter as an eight-hour time-weighted average, with an excursion limit of 1.0 fiber per cubic centimeter over any 30-minute period — but those limits protect workers in factories and refineries, not mothers applying baby powder in their own homes. The consumer who shakes talc into the air of a bathroom has no federal protection at all.
That regulatory gap is not a defense for Johnson & Johnson. It is an indictment of the system that was supposed to protect people. The absence of a federal testing requirement does not mean the product was safe — it means no one was checking. And in the absence of government checking, the burden of safety enforcement falls on product liability litigation. The $32 million verdict in Los Angeles is not just compensation for one family — it is the enforcement mechanism that the regulatory framework failed to provide.
Who Johnson & Johnson Really Is — The Corporate Structure and the Bankruptcy Tactic
Johnson & Johnson is one of the largest pharmaceutical and consumer products companies in the world. Its talc liability has been shuffled through a chain of entities that reads like a corporate engineering project:
The historical talc seller was Johnson & Johnson Consumer Inc. When the litigation grew to tens of thousands of cases, the company created a subsidiary called LTL Management LLC to hold the talc liability, using a corporate maneuver known as the “Texas two-step” — a divisional merger that splits a company into two entities, one holding the assets and the other holding the liabilities, and then pushes the liability entity into bankruptcy. LTL Management filed for Chapter 11. Twice. Both filings were dismissed by courts that saw the maneuver for what it was — an attempt to use bankruptcy to cap liability without the company actually being in financial distress.
A third attempt followed, using an entity renamed Red River Talc LLC. On March 31, 2025, the U.S. Bankruptcy Court for the Southern District of Texas denied confirmation and dismissed that prepackaged Chapter 11 as well, citing vote-solicitation irregularities and impermissible nonconsensual third-party releases. Three attempts. Three failures. The cases are back in the tort system — which is exactly where the Los Angeles verdict happened.
Meanwhile, Johnson & Johnson spun off its consumer health business into a separate publicly traded company called Kenvue Inc. — the entity that now owns brands like Band-Aid, Tylenol, and Listerine. Johnson & Johnson retained indemnity arrangements for the talc liability, but the corporate restructuring means the entity that sold the powder, the entity that holds the liability, and the entity that holds the assets may all be different companies.
All of this matters because it affects who you sue, who pays, and how long collection takes. The consolidated federal multidistrict litigation — MDL-2738, In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation — had 68,029 actions pending as of June 2026, before Judge Michael A. Shipp in the District of New Jersey. That is the federal backlog. The Los Angeles case was a state-court trial, and the $32 million verdict will be subject to post-trial motions and potentially appeal — meaning collection is a process, not an event.
The largest affirmed verdict in the talc litigation is the Ingham case from Missouri — a jury verdict of $4.69 billion that the Missouri Court of Appeals reduced to approximately $2.12 billion, and which the U.S. Supreme Court declined to review in June 2021. That reduced figure stands as a final, affirmed recovery. The article also references a $1.5 billion verdict from a Baltimore jury in December 2025 — reported as the largest such judgment ever delivered — but that verdict’s current appellate status has not been confirmed, and any verdict of that magnitude will face post-trial challenges before it becomes final. Past results depend on the facts of each case and do not guarantee future outcomes.
What a Talc-Mesothelioma Case Is Worth in California
The $32 million verdict in Los Angeles reflects the combined weight of several damage categories that California law makes available in a wrongful death and survival action arising from a defective product. Let us walk through them.
Wrongful death damages belong to the surviving family — here, the three children. California’s wrongful death statute allows statutory heirs to recover for the loss of financial support the decedent would have provided, the loss of companionship, guidance, and emotional support, and funeral and burial expenses. These are not speculative losses. A life-care planner and forensic economist build them from the decedent’s earning history, the family’s financial interdependence, and actuarial tables that project what the support would have been over the decedent’s expected remaining working life. For a mother who was central to her children’s lives, the non-economic loss — the lost guidance, the lost relationship, the empty chair at every future family gathering — carries its own weight, and California does not cap non-economic damages in product liability cases.
Survival action damages belong to the estate and recover what the decedent herself lost between diagnosis and death: the pain and suffering of living with mesothelioma, the medical expenses of treatment, and the lost earnings during the period between diagnosis and death. Mesothelioma treatment is brutal — chemotherapy, potentially surgery, radiation — and the disease progresses with relentless breathing deterioration, chest pain, and fluid accumulation that requires repeated draining. The survival action compensates the person who went through that, through their estate.
Punitive damages are available in California upon a showing by clear and convincing evidence of malice, oppression, or fraud. The evidence that Johnson & Johnson knew about asbestos contamination in its talc products and concealed that information from consumers, regulators, and the public is the evidence that supports a punitive damages claim. The purpose of punitive damages is not to compensate — it is to punish and to deter. A company with Johnson & Johnson’s resources is not deterred by a compensatory verdict alone. The punitive component is what makes the verdict sting.
The case-value range for comparable J&J talc-asbestos mesothelioma wrongful death cases runs from a low end of approximately $10 million to a high end of $75 million or more, depending on the strength of the specific causation evidence, the jurisdiction, the punitive damages exposure, and the decedent’s age, earning capacity, and family structure. The $32 million verdict falls squarely in the middle of that range — a significant recovery for a sole-fault finding in a plaintiff-favorable venue like Los Angeles, but not an outlier. Los Angeles County juries have historically demonstrated willingness to impose significant compensatory and punitive damages against corporate defendants in mass tort cases, particularly where internal corporate knowledge of a hazard is shown. The Los Angeles Superior Court system handles a substantial volume of complex product liability litigation and has experienced judges familiar with the scientific and evidentiary complexities of asbestos and toxic exposure cases.
One important note on damages: compensatory wrongful-death and physical-injury recoveries are generally federally tax-free under 26 U.S.C. § 104(a)(2). Punitive damages and interest are generally taxable. How a settlement or verdict is structured matters for the family’s tax position — and that is a conversation for the attorney and the family’s tax advisor, not a guess.
The Defense Playbook — What Johnson & Johnson Will Try and How to Answer It
Johnson & Johnson has now faced more than 60,000 talc-related lawsuits. The defense playbook is well-established, and it is built around one goal: shifting the cause of the mesothelioma away from the company’s product and onto anything else.
Play 1: Alternative causation — “the asbestos came from somewhere else.” In this Los Angeles case, the company argued that the woman’s first 21 years in Mexico City caused her asbestos exposure. The defense will comb the plaintiff’s residential, occupational, and family history for any other possible source of asbestos — a parent who worked with asbestos, a building with asbestos insulation, a school with asbestos tiles, an old car with asbestos brakes. The counter is specific causation evidence: a board-certified pathologist performs fiber analysis on lung tissue to identify the types and quantities of asbestos fibers present, and an industrial hygienist reconstructs the cumulative exposure dose from the talc product. The fiber types found in the tissue must be consistent with the type of asbestos that contaminates cosmetic talc — primarily amphibole fibers like tremolite, anthophyllite, or chrysotile — and the exposure dose from decades of daily talc use must be sufficient to account for the disease. When that evidence is strong, the alternative-causation argument falls apart, as it did in this case.
Play 2: Causation challenge — “you cannot prove this specific product caused this specific cancer.” The defense argues that mesothelioma has multiple causes and that the plaintiff cannot exclude every other possible exposure. The counter rests on the signature nature of mesothelioma: it is a disease that is essentially specific to asbestos, and the exposure history must be reconstructed with enough specificity to show that the talc product was a substantial contributing factor. Expert witnesses — a pathologist, an industrial hygienist, a geologist who can explain talc-asbestos co-occurrence, and a corporate governance expert who can interpret the company’s internal documents — form the team that builds this proof.
Play 3: The bankruptcy tactic — “let the courts wait.” Johnson & Johnson has used the bankruptcy system three times to try to freeze or cap the litigation. Each attempt has failed, but the strategy is not purely about winning the bankruptcy — it is about delay, about wearing down plaintiffs, about pushing settlements at discounted values. The counter is vigilance: tracking the corporate restructuring, naming the correct entities, and being prepared to fight collection challenges even after a verdict is obtained.
Play 4: The quick settlement offer. In some cases, the company or its insurers may offer a fast settlement — one that arrives before the full extent of the harm is documented, before the punitive damages evidence is developed, and before the family understands the true value of the case. The counter is simple: never accept a settlement before the medical records, the exposure history, and the corporate knowledge evidence are fully developed. The first offer is designed to close the case cheaply. It is not designed to be fair.
The Evidence That Is Disappearing Right Now
Every talc-mesothelioma case turns on evidence that is perishable — some of it on a clock that is already running against you.
Pathology slides and tissue blocks. The single most important piece of specific-causation evidence is the decedent’s lung tissue, analyzed for asbestos fiber type and count. These tissue blocks and slides are held by the treating hospital’s pathology department. Institutional retention policies vary — typically 7 to 10 years — but some facilities dispose of them sooner. If the decedent died in 2024, the tissue may still exist, but it will not exist forever. A preservation demand to the pathology department must go out immediately.
Talc product samples and purchase receipts. If the family still has containers of the Johnson & Johnson baby powder that was used, those containers can be forensically tested for asbestos contamination — directly linking the specific product in the home to the asbestos fibers in the lungs. The product was discontinued in 2020, meaning no new stock is being produced. Remaining household supplies and old receipts may be lost as the estate is administered and property is dispersed. Family members should secure any remaining product containers, old purchase receipts, and anything that documents the decades-long usage pattern.
Medical records. The complete medical record — pathology reports, imaging studies, treatment records, chemotherapy administration records, hospice records — establishes the diagnosis, the treatment course, the pain and suffering, and the medical expenses. These are generally retained by providers but should be formally requested and copied before any institution’s retention policy allows destruction.
Family testimony about usage history. The exposure reconstruction depends on testimony from family members who can describe the decedent’s baby powder usage — how often, how much, on whom, for how many years. Memory degrades. People move, age, and pass away. The deposition of each family member who can testify to the usage pattern should be taken while the testimony is fresh and the witness is available. In this Los Angeles case, the decedent’s three children were the ones who could testify to the decades of use — and they carried the case forward after her death.
Johnson & Johnson internal corporate documents. Much of the corporate knowledge evidence — internal testing results, asbestos detection reports, safety deliberations, marketing materials — has already been produced in the MDL and in prior trial discovery. But case-specific document custodian holdings must be identified through targeted discovery, and corporate retention policies may allow destruction of some materials over time. The company’s marketing and advertising materials targeting Hispanic and Latino consumers may also be relevant — they can show that the company marketed specifically to the communities and demographics most affected, supporting the foreseeability of the specific use pattern.
The preservation letter — a formal demand that these records be frozen and not destroyed — is the first thing that goes out when you call us. Not after the funeral. Not after you have had time to think. The day you call is the day the clock starts working for you instead of against you.
How a Talc-Mesothelioma Case Is Built — From First Call to Verdict
Here is the chronological walk of how a case like the Los Angeles $32 million verdict is actually built.
Week one. The preservation letter goes out — to Johnson & Johnson, to the pathology department that holds the tissue blocks, to any pharmacy or retailer with purchase records, and to any other entity that holds evidence. The letter freezes the records. After that letter, if evidence disappears, the law has an answer: an adverse-inference instruction, where the jury may assume the lost evidence was as bad for the company as the plaintiff says it was.
Weeks two through eight. The medical records are assembled — every pathology report, every imaging study, every treatment note. The exposure history is documented through family interviews: when did the usage start, how often, what product, applied to whom, for how many years. Every detail matters. The family member who remembers the smell of the powder in the bathroom, the one who remembers their mother applying it after every bath, the one who has the old bottle in a closet — each is a piece of the exposure reconstruction.
Months two through six. Expert witnesses are retained. A board-certified pathologist examines the tissue slides and identifies the asbestos fiber types. An industrial hygienist models the cumulative exposure dose from decades of talc application. A geologist explains how talc and asbestos co-occur in nature and how mining contamination works. A corporate governance expert reviews Johnson & Johnson’s internal documents and builds the timeline of what the company knew and when.
Months six through twelve. Discovery proceeds. The company produces documents — internal testing results, safety committee minutes, marketing strategies, communications with regulators. Depositions are taken: the corporate witnesses who can explain the testing protocols (or the absence of testing), the scientists who can explain what the company knew about asbestos contamination, the marketing executives who can explain how the product was sold to families as safe and pure.
Year one through trial. The case is prepared for trial. The expert reports are finalized. The exhibit list is built. The deposition testimony is organized. The trial strategy is locked: strict liability for a defective product, failure to warn of a known hazard, punitive damages for corporate concealment. The alternative-causation defense is preempted by locking down the exposure history during family depositions — every residential address, every job, every possible other asbestos source is identified and either excluded or accounted for in the dose reconstruction.
Trial. The jury hears the science — how talc and asbestos grow together, how the fibers travel from powder to lung, how the latency period works. They hear the corporate documents — what the company knew and when. They hear the family — what was lost. And they return a number.
That is how $32 million happens. It is not luck. It is work, science, and evidence — assembled by people who know exactly what to look for.
Your First 72 Hours — What to Do and What Not to Do
If someone in your family has been diagnosed with mesothelioma and has a history of using talc-based baby powder, the clock is already running. Here is what to do in the first 72 hours.
Day one. Call a lawyer. Not a general practice lawyer — a trial firm that handles toxic tort and product liability cases and understands the specific science of asbestos causation. The consultation is free. The fee is contingency — you pay nothing unless the firm wins your case. The reason to call on day one is not pressure. It is evidence. The pathology tissue blocks are on a retention timer. The product samples are disappearing with estate administration. The family testimony is freshest now, not in six months.
Day one. Secure any remaining product. If there are old containers of Johnson & Johnson baby powder in the home, do not throw them away. Do not open them. Place them in a sealed bag and store them safely. These containers can be tested for asbestos contamination, and a positive test is direct evidence linking the specific product to the exposure.
Day one. Write down the usage history. While memory is fresh, write down everything: when the usage started, how often the powder was applied, to whom it was applied, what brand was used, where it was purchased, and whether it was used on children. Ask other family members to do the same. These written recollections become the foundation of the exposure reconstruction.
Day two. Request medical records. Contact every treating physician, every hospital, every imaging center, and every pathology department. Request the complete record — not just the reports, but the actual tissue blocks and slides. These belong to the family, and they are the single most important piece of specific-causation evidence.
Day two. Do not sign anything from any insurance company, claims administrator, or representative of Johnson & Johnson. Do not give a recorded statement. Do not accept a quick settlement check. Do not post about the case on social media. The company is already building its defense — the alternative-causation research, the exposure history investigation, the surveillance. Everything you say can and will be used to reduce the value of your case.
Day three. Do not talk to the company’s representatives. If someone calls claiming to be from Johnson & Johnson or from a claims office, take their name and number and give them nothing. Refer them to your attorney. If you have not yet retained an attorney, tell them you will call them back — and then call us.
Day three. Identify witnesses. Who else knew about the baby powder usage? Who saw it applied daily? Who can testify to the decades-long pattern? Make a list. These people are your corroborating witnesses, and their memories are on the same decay schedule as yours.
The Medicine — What Mesothelioma Does to the Body and to the Family Watching It Happen
Pleural mesothelioma is an aggressive, universally fatal malignancy of the pleural mesothelium — the thin membrane that lines the lungs and the chest wall. Median survival from diagnosis is 12 to 21 months. There is no cure. Treatment is multimodal and intense: platinum-based chemotherapy (typically pemetrexed and cisplatin), potentially surgery (extrapleural pneumonectomy or pleurectomy/decortication), and radiation. All of these produce severe side effects — nausea, fatigue, hair loss, surgical pain, radiation burns, and progressive loss of pulmonary function.
The disease progresses through the pleura, thickening it, restricting lung expansion, and producing pleural effusions — fluid accumulations between the pleural layers that compress the lung and cause breathlessness. These effusions require repeated drainage through thoracentesis, a needle procedure that provides temporary relief but does not stop the underlying disease. As the cancer advances, it causes chest pain, cough, weight loss, fatigue, and eventually respiratory failure.
The family watches this happen. They watch someone who was healthy — who had no symptoms, who was active, who was present — transform over months into someone who cannot breathe without oxygen, cannot eat without nausea, and cannot sleep without pain. The diagnosis comes out of nowhere because the latency is decades long. There was no warning. There was no gradual onset. There was a healthy person and then there was a dying person, and the gap between those two states is the latency period of asbestos.
This is what the survival action compensates. Not just the medical bills — the experience of dying from a disease that was put inside you by a product you trusted. The pain, the fear, the loss of dignity, the knowledge that the cancer was preventable. That is what a jury hears, and that is what a jury values.
The cost of mesothelioma treatment runs into hundreds of thousands of dollars — chemotherapy regimens, surgical procedures, hospital stays, imaging, palliative care, hospice. The medical expenses alone can exceed what many families can absorb. The lost wages from the period between diagnosis and death — the decedent’s final working months or years, cut short — add to the economic loss. And the wrongful death damages compensate the family for the financial support, the companionship, and the guidance that were taken from them.
The Statute of Limitations — How Long You Have and When the Clock Starts
California’s statute of limitations for personal injury and wrongful death actions is generally two years. For toxic tort cases involving latent disease — like mesothelioma, which can take decades to appear — California applies the discovery rule: the clock does not start on the date of exposure. It starts when the plaintiff knew, or by reasonable diligence should have known, of the injury and its causal connection to the exposure.
For a mesothelioma diagnosis, the discovery rule typically means the personal injury clock starts around the date of diagnosis — the date the person learned they had the disease. For a wrongful death claim, the clock runs from the date of death. For a survival action (the estate’s claim for the decedent’s pre-death damages), the accrual date may be tied to when the decedent discovered or should have discovered the injury and its cause.
This means: if your loved one was diagnosed in 2023 and died in 2024, the personal injury claim may have accrued around the diagnosis date, and the wrongful death claim accrued on the date of death. Both are subject to a two-year deadline — but the specific accrual analysis depends on the facts of each case, and some states impose an outer deadline (a statute of repose) that can cut off a claim even before discovery. This is not a question to answer from a website. It is a question to answer with an attorney who can look at your specific dates and your state’s specific rules.
The urgency is real. If you are outside the two-year window from diagnosis or death, do not assume the case is over — call us. The discovery rule, equitable tolling, and other doctrines may still preserve the claim. But do not wait to find out.
Frequently Asked Questions
Can I sue Johnson & Johnson if my family member used baby powder and developed mesothelioma?
Yes — if you can establish that the mesothelioma was caused by inhalation of asbestos fibers from Johnson & Johnson’s talc-based baby powder. The case requires specific causation evidence: pathology tissue analysis showing asbestos fiber types consistent with cosmetic talc contamination, an exposure history documenting decades of product use, and expert testimony linking the exposure to the disease. A Los Angeles jury just did exactly this and returned a $32 million verdict. The strength of your case depends on the quality of the evidence — which is why preserving pathology tissue, product samples, and family testimony is urgent.
How long do I have to file a talc-mesothelioma lawsuit in California?
California’s statute of limitations for personal injury and wrongful death is generally two years, but for mesothelioma and other latent diseases, the discovery rule applies — meaning the clock typically starts when the person knew or should have known of the injury and its cause, not when the exposure occurred. For a wrongful death claim, the deadline generally runs from the date of death. Because the specific accrual date depends on the facts of your case, you should speak with an attorney immediately to confirm your deadline. Do not assume it is too late until a lawyer has looked at your dates.
What if my loved one also lived in a place with possible environmental asbestos exposure?
That is exactly the defense Johnson & Johnson raised in the Los Angeles case — arguing that the woman’s years in Mexico City caused her exposure. The jury rejected it. The counter is specific causation evidence: fiber analysis of lung tissue showing asbestos types consistent with talc contamination, an industrial hygiene exposure reconstruction quantifying the cumulative dose from baby powder use, and a comprehensive exposure history that accounts for every possible alternative source. If the talc exposure dose is sufficient to account for the disease, and the alternative sources are not, the jury can find the product was the cause.
How much is a talc-mesothelioma case worth?
Case values in comparable J&J talc-asbestos mesothelioma wrongful death cases range from approximately $10 million to $75 million or more, depending on the strength of the specific causation evidence, the venue, the punitive damages exposure, and the decedent’s age, earning capacity, and family structure. The $32 million Los Angeles verdict reflects a mid-range outcome for a sole-fault finding in a plaintiff-favorable venue. The largest affirmed verdict in the talc litigation is approximately $2.12 billion (Ingham, Missouri — reduced from $4.69 billion and upheld). Past results depend on the facts of each case and do not guarantee future outcomes.
What if Johnson & Johnson files for bankruptcy again?
The company has tried three times to use bankruptcy to wall off its talc liability — through LTL Management LLC and then Red River Talc LLC. All three attempts were dismissed. The cases are back in the tort system. If the company attempts another bankruptcy filing, it does not automatically end your right to sue — but it can complicate collection and delay proceedings. An experienced trial firm tracks the corporate restructuring and is prepared to fight both the trial and the collection challenges Johnson & Johnson has engineered.
Do I need to have the actual baby powder container to prove my case?
It strengthens the case significantly but is not always required. A retained product container can be forensically tested for asbestos contamination, providing direct evidence linking the specific product to the exposure. Without a container, the case relies on testimony about product usage, purchase records, and the specific-causation evidence from tissue analysis. Because the product was discontinued in 2020, remaining containers are becoming harder to find — if your family still has any, secure them immediately.
Will I have to go to trial?
Most product liability cases settle before trial, but the strongest settlements come from cases that are fully prepared for trial. Johnson & Johnson has shown it will try cases — and sometimes lose them, as the $32 million Los Angeles verdict demonstrates. The decision to settle or try a case is yours, not the lawyer’s. Our role is to build the case to its maximum strength so that whether it resolves by settlement or verdict, the value is real.
Is the compensation taxable?
Compensatory damages for personal physical injury or physical sickness — including wrongful death compensation — are generally excluded from gross income under federal law (26 U.S.C. § 104(a)(2)). Punitive damages and interest are generally taxable. The specific tax treatment depends on how the recovery is structured, and you should consult a tax advisor about your individual situation. This is legal information, not tax advice.
What does it cost to hire Attorney911?
Nothing upfront. We work on contingency — 33.33% before trial, 40% if the case goes to trial. We do not get paid unless we win your case. The consultation is free. You can call us at 1-888-ATTY-911, 24 hours a day, and speak with a live person — not an answering service.
Can I still file a claim if my loved one has already passed away?
Yes. In California, a wrongful death claim can be brought by the decedent’s statutory heirs — typically the surviving spouse and children. A survival action can be brought by the estate to recover the decedent’s pre-death damages, including pain and suffering, medical expenses, and lost earnings. The personal representative of the estate is the person California law authorizes to bring the family’s case. We handle that appointment as part of the work.
Why This Firm
Ralph Manginello has spent 27 years in courtrooms, including federal court. He is admitted to the U.S. District Court for the Southern District of Texas. He was a journalist before he was a lawyer — which means he knows how to find the story the documents tell, and he knows how to tell it to a jury. He handles the complex litigation that corporate defendants try to bury in paper and delay. He does not like losing, and the families he represents are not people he forgets when the verdict comes in.
Lupe Peña spent years inside a national insurance-defense firm — the rooms where adjusters and their software decided how to deny, delay, and devalue claims from people exactly like the ones we now represent. He sat in the meetings where claim values were set, where IME doctors were selected, where surveillance was ordered, where settlement offers were engineered to look generous while being a fraction of what the case was worth. He knows how the other side values a claim because he was the other side. Now he uses that knowledge for injured clients. He is fluent in Spanish and conducts full consultations in Spanish without an interpreter — hablamos Español — because the family that prays in Spanish deserves to understand their rights in the same language.
Together, they lead a trial team that takes California cases — working with local counsel and pro hac vice admission where required. The firm is based in Houston, Texas, with offices in Austin and Beaumont, and handles toxic tort, wrongful death, and catastrophic injury litigation across state lines. The firm has recovered more than $50 million for clients over its history, including a $5 million brain-injury settlement, a $3.8 million amputation settlement, and millions in trucking wrongful-death cases. Past results depend on the facts of each case and do not guarantee future outcomes.
The work we do on a case like this is not theoretical. It is the preservation letter that goes out the day you call. It is the pathology demand that secures the tissue blocks before they are destroyed. It is the expert witnesses we retain — the pathologist, the industrial hygienist, the geologist, the corporate governance analyst — who build the proof that ties the powder to the cancer. It is the depositions where the company’s own witnesses explain, under oath, what they knew and when they knew it. And it is the trial — the story told to twelve people from the community who decide what a life was worth and what a company’s concealment should cost.
You can learn more about our practice areas or contact us directly. The call is free. The consultation is confidential. And we do not get paid unless we win your case.
Call 1-888-ATTY-911. Any hour. Any day. We answer — because the evidence clock does not wait for business hours.